Tag: Rules & Regulations

FDA extends UDI compliance dates for Class I, unclassified devices

Editor's Note The Food and Drug Administration (FDA) has notified medical device labelers that the compliance dates for unique device identifier (UDI) requirements for Class I and unclassified medical devices has been extended from September 24, 2018, to September 24, 2020, and for direct mark requirements from September 24, 2020,…

Read More

By: Judy Mathias
June 12, 2017
Share

Joint Commission: Changes to post-survey processes, decision rules

Editor's Note The Joint Commission on February 22 announced that recent changes had been made to simplify and streamline the accreditation post-survey process and decision rules. Among the changes: An organization with an accredited with follow-up decision will receive full accreditation once it has successfully submitted evidence of standards compliance.…

Read More

By: Judy Mathias
February 24, 2017
Share

Editorial

Even before Trump took office, Congress was planning to prepare ACA repeal legislation by January 27. It looked as though action could be swift once key members of the new administration took office. However, The Washington Post’s report of a January 26 meeting of Republican lawmakers indicated they were far…

Read More

By: Elizabeth Wood
February 17, 2017
Share

CMS immediate jeopardy trail may lead to the OR

What makes an OR subject to an immediate jeopardy finding from a Medicare inspection? Immediate jeopardy is cited when a provider’s noncompliance with one or more of the Centers for Medicare & Medicaid’s (CMS) Conditions of Participation causes or is likely to cause serious injury, harm, impairment, or death.  …

Read More

By: Judith M. Mathais, MA, RN
February 17, 2017
Share

DNV accreditation: A positive spin on survey preparation

There is a lot of buzz in the healthcare community about a newcomer to the accreditation process. For many years, the Joint Commission was the first choice for providing accreditation for hospitals in the US. But Norway-based Det Norske Veritas (DNV) is gaining ground, representing more than 350 hospitals and…

Read More

By: Judith M. Mathais, MA, RN
February 17, 2017
Share

Mass ASCs can offer more procedures without hospital affiliation

Editor's Note New Massachusetts (Mass) state regulations approved January 11 allow freestanding ambulatory surgery centers (ASCs) to apply for permission to expand or offer new lines of procedures without being affiliated with an acute care hospital, the January 19 Enterprise News reports. The new regulations lift a 20-year moratorium on…

Read More

By: Judy Mathias
January 24, 2017
Share

CRNAs not included in new VA nurse practice rule

Editor's Note The Department of Veterans Affairs (VA) on December 13 issued a final rule allowing full practice authority for certain advanced practice registered nurses working in VA facilities, including certified nurse practitioners, clinical nurse specialists, and certified nurse midwives. The rule excludes certified registered nurse anesthetists (CRNAs), following lobbying…

Read More

By: Judy Mathias
December 14, 2016
Share

ASCA lauds passage of 21st Century Cures Act

Editor's Note The Ambulatory Surgery Center Association (ASCA) on December 7 applauded Congress for passing the 21st Century Cures Act, which includes two provisions that benefit Medicare patients and physicians in ambulatory surgery centers (ASCs). The first provision, Section 4012, directs the Department of Health and Human Services (HHS) to…

Read More

By: Judy Mathias
December 9, 2016
Share

Deadline for ASC nondiscrimination requirements is Oct 19

Editor's Note Ambulatory surgery centers (ASCs) must comply with nondiscrimination requirements in Section 1557 of the Affordable Care Act by October 19, the Ambulatory Surgery Center Association announced on September 28. The Act prohibits sex discrimination and requires language assistance for those with limited English proficiency and effective communication for…

Read More

By: Judy Mathias
September 29, 2016
Share

FDA expands indication for two transcatheter aortic valves

Editor's Note The Food and Drug Administration (FDA) on August 18 approved an expanded indication for the Sapien XT and Sapien 3 transcatheter heart valves for patients with aortic stenosis. The new indication is for patients who are at intermediate risk for death or complications associated with open-heart surgery. Previously,…

Read More

By: Judy Mathias
August 24, 2016
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat